Cargando…

Neutrophils as a Novel Target of Modified Low-Density Lipoproteins and an Accelerator of Cardiovascular Diseases

Neutrophil extracellular traps (NETs) significantly contribute to various pathophysiological conditions, including cardiovascular diseases. NET formation in the vasculature exhibits inflammatory and thrombogenic activities on the endothelium. NETs are induced by various stimulants such as exogenous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obama, Takashi, Itabe, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664187/ https://www.ncbi.nlm.nih.gov/pubmed/33167592 http://dx.doi.org/10.3390/ijms21218312

Ejemplares similares

High-Density Lipoprotein Suppresses Neutrophil Extracellular Traps Enhanced by Oxidized Low-Density Lipoprotein or Oxidized Phospholipids
por: Ohinata, Hitomi, et al.
Publicado: (2022)

Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein
por: Itabe, Hiroyuki, et al.
Publicado: (2021)

Cooperative Action of Oxidized Low-Density Lipoproteins and Neutrophils on Endothelial Inflammatory Responses Through Neutrophil Extracellular Trap Formation
por: Obama, Takashi, et al.
Publicado: (2019)

The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation
por: Itabe, Hiroyuki, et al.
Publicado: (2023)

Transfer and Enzyme-Mediated Metabolism of Oxidized Phosphatidylcholine and Lysophosphatidylcholine between Low- and High-Density Lipoproteins
por: Sawada, Naoko, et al.
Publicado: (2020)

Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis
por: Itabe, Hiroyuki
Publicado: (2012)

Investigation of Lipoproteins Oxidation Mechanisms by the Analysis of Lipid Hydroperoxide Isomers
por: Kato, Shunji, et al.
Publicado: (2021)

Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein
por: Sasabe, Naoko, et al.
Publicado: (2014)

The Dynamics of Oxidized LDL during Atherogenesis
por: Itabe, Hiroyuki, et al.
Publicado: (2011)

Aggregation Susceptibility of Low-Density Lipoproteins—A Novel Modifiable Biomarker of Cardiovascular Risk
por: Öörni, Katariina, et al.
Publicado: (2021)

Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease?
por: Whyte, Martin B
Publicado: (2019)

Crucial Role of Perilipin-3 (TIP47) in Formation of Lipid Droplets and PGE(2) Production in HL-60-Derived Neutrophils
por: Nose, Fuyuki, et al.
Publicado: (2013)

Sar1 Affects the Localization of Perilipin 2 to Lipid Droplets
por: Makiyama, Tomohiko, et al.
Publicado: (2022)

High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease
por: Kapur, Navin K, et al.
Publicado: (2008)

Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges
por: Packard, Chris, et al.
Publicado: (2021)

Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies
por: Delporte, Cédric, et al.
Publicado: (2013)

Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease
por: Patel, Parth N., et al.
Publicado: (2020)

High density lipoproteins-based therapies for cardiovascular disease
por: Gao, Xuan, et al.
Publicado: (2010)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
por: Lawler, Patrick R., et al.
Publicado: (2017)

Current Status of Low-Density Lipoprotein Cholesterol and Cardiovascular Diseases in Japan
por: Sun, Wanlu, et al.
Publicado: (2023)

Comparison of protein profiles of the pellicle, gingival crevicular fluid, and saliva: possible origin of pellicle proteins
por: Odanaka, Hibiki, et al.
Publicado: (2020)

Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy
por: Lin, Yun, et al.
Publicado: (2010)

Low density Lipoprotein cholesterol target: Changing goal posts
por: Bantwal, Ganapathi, et al.
Publicado: (2012)

Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease
por: Orekhov, Alexander N., et al.
Publicado: (2014)

A Strict Target for Low-Density Lipoprotein Cholesterol May not Be Necessary for Secondary Prevention of Cardiovascular Disease in All Elderly Patients With Dyslipidemia
por: Miura, Shin-ichiro, et al.
Publicado: (2020)

Targeting PCSK9 and Beyond for the Management of Low-Density Lipoprotein Cholesterol
por: Mohamed, Farzahna, et al.
Publicado: (2023)

Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk
por: Sharma, Rakesh K, et al.
Publicado: (2009)

Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
por: Estrada-Luna, Diego, et al.
Publicado: (2018)

Lipid composition of circulating multiple-modified low density lipoprotein
por: Zakiev, E. R., et al.
Publicado: (2016)

Carbohydrate composition of circulating multiple-modified low-density lipoprotein
por: Zakiev, Emile R, et al.
Publicado: (2016)

High-Density Lipoproteins in Non-Cardiovascular Diseases
por: Zanotti, Ilaria
Publicado: (2022)

Serum Lipid, Lipoprotein and Oxidatively Modified Low Density Lipoprotein Levels in Active or Inactive Patients with Behçet's Disease
por: Cimen, Fuat, et al.
Publicado: (2012)

Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease
por: Gao, Shen, et al.
Publicado: (2017)

Low‐Density Lipoprotein Cholesterol Attributable Cardiovascular Disease Risk Is Sex Specific
por: Cupido, Arjen J., et al.
Publicado: (2022)

Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
por: Kornmueller, Karin, et al.
Publicado: (2019)

Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease
por: Ishii, Junnichi, et al.
Publicado: (2022)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Low-Density Lipoprotein Cholesterol Target Attainment in Patients With Established Cardiovascular Disease: Analysis of Routine Care Data
por: Groenhof, T Katrien J, et al.
Publicado: (2020)

On the origin of low‐density neutrophils
por: Hassani, Marwan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tl8q9lgl79v96j2gls013f9tor